Latest long-term debt for RENX: $4.5M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for RENX is $4.5M as of March 2026. That compares with $820K in the prior-year period — up 451.7% year over year. Investors often review this figure alongside RenX Enterprises's historical trend and sector peers before judging valuation or financial health.
Over the past year, RENX's long-term debt moved from $820K to $4.5M — a 451.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RenX Enterprises's operating scale or balance-sheet position.
A long-term debt figure of $4.5M for RENX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting RENX's long-term debt ($4.5M), review year-over-year change from $820K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack RenX Enterprises's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.